Nuwellis Reports Q3 2026 Revenue of $2.2 Million and Improved Operating Loss
Nuwellis, Inc. (NUWE) reported third-quarter 2026 revenue of $2.2 million, remaining flat year-over-year due to a high comparison base from prior backorder fulfillment. However, the company demonstrated underlying momentum with a 12% sequential revenue increase from Q2 2026 and a 13% increase in nine-month revenue driven by U.S. circuit and console sales. The company achieved significant margin expansion, reaching a 70% gross margin due to higher average selling prices and a transition to contract manufacturing. While the company reported a net loss of $2 million compared to a profit last year, operating losses improved by 24%. Management highlighted strong pediatric segment growth and recent FDA submissions to expand product indications.
Tickers: $NUWE